Your session is about to expire
← Back to Search
Subanesthetic ketamine for Mechanical Ventilation
Study Summary
This trial is testing whether ketamine can help keep people on a ventilator by improving their breathing and reducing the amount of opioids and propofol needed.
- Mechanical Ventilation
- Airway Obstruction
- Respiratory Depression
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the primary objective of this clinical experiment?
"This trial's primary aim is to evaluate the effect of ketamine on tidal volume, and secondary outcomes include confusion assessment measurement for the ICU (CAM-ICU), oxygen blood saturation as measured by pulse oximetry, and number of days mechanically ventilated. Data points will be recorded 15 minutes before ketamine infusion begins, at 60 minute intervals during 5mcg/kg/min and 10mcg/kg/min infusions respectively, then again two hours after stoppingthe infusion."
How many individuals are involved in this research endeavor?
"This clinical trial has already closed recruitment and was last modified on November 8th 2022. That said, there are still 209 studies recruiting for mechanical ventilation treatments and 105 trials looking to enroll subjects that plan to use subanesthetic ketamine."
Are there any opportunities for prospective participants to join this experiment?
"This medical experiment is no longer registering participants. It was initially posted on January 1st 2014, with the latest update occurring on November 8th 2022. For those searching for similar studies, 209 clinical trials are currently recruiting patients requiring ventilation and 105 studies examining subanesthetic ketamine's therapeutic potential are actively enrolling subjects."
Share this study with friends
Copy Link
Messenger